1. This research will contribute to the construction of a detailed cytological map of the human genome in which the locations of genes and linkage groups are established with respect to visible features on the chromosomes. It will focus on assignment of genes involved in growth control, in development and in genetic disorders. This mapping information will lead to testable hypotheses regarding the involvement of specific genes in certain types of malignancies, in the pathogenesis of malformation syndromes and in specific Mendelian phenotypes. These efforts will be extended to the mouse genome in order to elucidate mammalian karyotype evolution and to develop mouse models for human genetic disorders based on the mapping of putative homologous mutations to conserved chromosomal regions. The approach will be to hybridize cloned gene probes to DNA from somatic cell hybrid panels that contain reduced sets of human or mouse chromosomes; and directly (in situ) to normal or rearranged human and mouse metaphase chromosomes. 2. The hypothesis that complex developmental disorders can be caused by DNA sequence rearrangements that give rise to deletion or abnormal expression of several genes will be tested. Pulsed-field-gradient gel electrophoresis and Southern blotting of large (100-1000kb) restriction fragments will be applied to DNA samples from patients with visible or suspected (submicroscopic) chromosome rearrangements, and specific disorders such as the Beckwith-Wiedemann syndrome, the Rett syndrome, cystic fibrosis with developmental abnormalities and others. Probes to be used will include """"""""candidate genes"""""""" and other DNA fragments that map nearby or are obtained by screening """"""""jumping libraries"""""""". Thus, a high-resolution physical map of the region involved in the clinical syndrome will be constructed that will then allow the identification of structural genomic abnormalities. The expression of genes mapped to this region can then be examined in the patients. 3. In two series of rat hepatoma x human fibroblast hybrids human liver-specific functions have been activated, and the responsible genes have been mapped. The molecular mechanisms of these gene activation phenomena will now be examined using cloned gene sequences. Parameters associated with differential gene activity will be tested, such as CpG methylation, chromatin structure (DNase I sensitivity) and the presence of trans-acting DNA binding proteins that interact with specific sequences of the cloned genes.

Agency
National Institute of Health (NIH)
Institute
National Human Genome Research Institute (NHGRI)
Type
Research Project (R01)
Project #
8R01HG000298-13
Application #
3333349
Study Section
Mammalian Genetics Study Section (MGN)
Project Start
1989-07-01
Project End
1992-06-30
Budget Start
1990-07-01
Budget End
1991-06-30
Support Year
13
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Stanford University
Department
Type
Schools of Medicine
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Franke, Y; Peoples, R J; Francke, U (1999) Identification of GTF2IRD1, a putative transcription factor within the Williams-Beuren syndrome deletion at 7q11.23. Cytogenet Cell Genet 86:296-304
Ring, H Z; Vameghi-Meyers, V; Nikolic, J M et al. (1999) Mapping of the KHSRP gene to a region of conserved synteny on human chromosome 19p13.3 and mouse chromosome 17. Genomics 56:350-2
Ring, H Z; Vameghi-Meyers, V; Min, H et al. (1999) The mouse Fubp gene maps near the distal end of chromosome 3. Genomics 56:357-8
Ring, H Z; Chang, H; Guilbot, A et al. (1999) The human neuregulin-2 (NRG2) gene: cloning, mapping and evaluation as a candidate for the autosomal recessive form of Charcot-Marie-Tooth disease linked to 5q. Hum Genet 104:326-32
Ring, H Z; Vameghi-Meyers, V; Wang, W et al. (1998) Five SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin (SMARC) genes are dispersed in the human genome. Genomics 51:140-3
Paperna, T; Peoples, R; Wang, Y K et al. (1998) Genes for the CPE receptor (CPETR1) and the human homolog of RVP1 (CPETR2) are localized within the Williams-Beuren syndrome deletion. Genomics 54:453-9
Wang, Y K; Perez-Jurado, L A; Francke, U (1998) A mouse single-copy gene, Gtf2i, the homolog of human GTF2I, that is duplicated in the Williams-Beuren syndrome deletion region. Genomics 48:163-70
Peoples, R J; Cisco, M J; Kaplan, P et al. (1998) Identification of the WBSCR9 gene, encoding a novel transcriptional regulator, in the Williams-Beuren syndrome deletion at 7q11.23. Cytogenet Cell Genet 82:238-46
Li, L; Li, X; Francke, U et al. (1997) The TSG101 tumor susceptibility gene is located in chromosome 11 band p15 and is mutated in human breast cancer. Cell 88:143-54
Carmeci, C; Thompson, D A; Ring, H Z et al. (1997) Identification of a gene (GPR30) with homology to the G-protein-coupled receptor superfamily associated with estrogen receptor expression in breast cancer. Genomics 45:607-17

Showing the most recent 10 out of 68 publications